Scientists find gene therapy reduces liver cancer in animal model

Researchers at UC Davis Comprehensive Cancer Center have shown that inhibiting a specific protein using gene therapy can shrink hepatocellular carcinoma (HCC) in mice. Silencing the galectin 1 (Gal1) protein, which is often over-expressed in HCC, also improved the anti-cancer immune response and increased the number of killer T cells inside tumors. The study was published in Acta Pharmaceutica Sinica B.

Individuals with high Alzheimer’s risk may use attention to process, rather than suppress, distracting stimuli

Alzheimer’s disease is a neurodegenerative condition that damages a person’s ability to think, remember, and perform basic functions. According to the National Institutes of Health, Alzheimer’s affects more than 6 million Americans, mostly ages 65 and older. Though the neurological damage from the disease is irreversible, its progression can be slowed by early interventions such as exercise and nutrition regimens. Thus, an early screening for Alzheimer’s risk can be vital in helping people manage and plan for their symptoms.

Parental engagement positively associated with safer driving among young people, study finds

Researchers from the Mind, Brain and Behaviour Research Centre (CIMCYC) at the University of Granada (UGR) have adapted the Family Climate for Road Safety Scale (FCRSS) for young drivers and their parents to the Spanish context in order to assess the validity and reliability of FCRSS measures, based on seven dimensions: modeling, feedback, communication, monitoring, commitment to road safety, messages, and limits.